文献速递疝与腹壁外科围术期管理与 ERAS急腹症与外科感染

加速康复方案减少微创腹股沟疝修补术后尿潴留

A steady stream of knowledge: decreased urinary retention after implementation of ERAS protocols in ambulatory minimally invasive inguinal hernia repair.
PubMed 文献 · Surg Endosc · 2022-01-04

该回顾性研究纳入2008至2021年单中心1097例微创腹股沟疝修补患者,比较ERAS方案实施前后术后尿潴留(POUR)与疼痛并发症。ERAS组POUR发生率显著低于非ERAS组(1.4% vs 4.2%,p=0.01),疼痛并发症无差异。无阿片类处方出院者POUR发生率为0%。

要点

  • ERAS方案实施后POUR发生率由4.2%降至1.4%(p=0.01)
  • 无阿片类处方出院患者POUR发生率为0%
  • 年龄、较高输液量及较高阿片类用量为POUR危险因素

核心结论

  • 实施日间ERAS方案可显著降低微创腹股沟疝修补术后尿潴留及阿片类使用率。

研究设计与样本

  • 回顾性审查前瞻性维护数据库,纳入2008年1月至2021年3月单中心1097例微创腹股沟疝修补患者,2018年后手术归入ERAS队列。

主要发现

  • ERAS组POUR发生率1.4% vs 非ERAS组4.2%(p=0.01),ERAS组显著降低。
  • 术后疼痛并发症ERAS组1.4% vs 非ERAS组2.9%(p=0.15),无显著差异。
  • 无阿片类处方出院患者POUR发生率为0%。
  • ERAS与非ERAS队列在阿片类使用和输液量方面存在显著差异。
  • 年龄、较高输液量、较高阿片类用量为POUR危险因素;ERAS、舒更葡糖、地塞米松为保护因素。

关键数值与推荐

  • POUR定义:出院时需留置导尿管、因尿潴留入院或返回急诊处理尿潴留。
  • 术后疼痛未控制定义:需额外阿片类处方、入院或因术后疼痛急诊就诊。
  • 91.3%手术为腹腔镜,8.7%为机器人;平均年龄57.4岁,93%为男性。

临床怎么用

  • 在微创腹股沟疝修补围术期实施日间ERAS方案,可能降低POUR风险。
  • 出院时避免阿片类处方与POUR发生率降低相关。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Potential complications after inguinal hernia repair include uncontrolled post-operative pain and post-operative urinary retention (POUR). Enhanced Recovery After Surgery (ERAS) protocols aim to mitigate post-operative morbidity. We study the impact of ERAS measures alongside discharge without a narcotic prescription on post-operative pain and POUR after minimally invasive inguinal hernia repair. METHODS: A retrospective review of a prospectively maintained database identified patients that underwent minimally invasive inguinal hernia repair at a single institution. Intra-operative data included operative time, narcotic usage, non-narcotic adjunct medication, and fluid administration. Primary outcomes included rates of POUR and uncontrolled post-operative pain. Operations performed after 2018 were included in the ERAS cohort. Uncontrolled post-operative pain was defined as needing additional narcotic prescriptions, admission, or ER visits for post-operative pain. POUR was defined as requiring an indwelling urethral catheter at discharge, admission for retention, or returning to the ER for urinary retention. RESULTS: Between January 2008 and March 2021, 1097 patients who underwent minimally invasive inguinal hernia repair were identified. 91.3% of these procedures were laparoscopic and 8.7% were robotic. Average patient age was 57.4 years, 93% were male. Patients receiving care after initiation of the ERAS protocol were significantly less likely to experience POUR when compared to their prior counterparts (1.4% vs. 4.2% p = 0.01); there was no difference in post-operative pain complications (1.4% vs. 2.9% p = 0.15). Patients who were discharged without a narcotic prescription had 0% incidence of POUR. Significant differences were found between the ERAS and non-ERAS cohort regarding narcotic usage and fluid administration. Age, higher fluid volume, and higher narcotic usage were found to be risk factors for POUR while ERAS, sugammadex, and dexamethasone were found to be protective. CONCLUSION: Implementation of an ambulatory ERAS protocol can significantly decrease urinary retention and narcotic usage rates after minimally invasive inguinal hernia repair.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Broderick RC, Li JZ, Blitzer RR, et al. A steady stream of knowledge: decreased urinary retention after implementation of ERAS protocols in ambulatory minimally invasive inguinal hernia repair. Surg Endosc. 2022. PMID: 34982228. doi:10.1007/s00464-021-08950-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。